Sergio
Vaño Galván
Profesor/a Asociado/a en CC. de la Salud


Pfizer (United States)
Nueva York, Estados UnidosPublications in collaboration with researchers from Pfizer (United States) (4)
2024
-
Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe
Dermatology and Therapy, Vol. 14, Núm. 12, pp. 3243-3258
-
Correction to: Alopecia Areata Treatment Patterns and Satisfaction: Results of a Real-World Cross-Sectional Survey in Europe (Dermatology and Therapy, (2024), 10.1007/s13555-024-01280-3)
Dermatology and Therapy
-
Impact of Previous Alopecia Areata Treatment on Efficacy Responses up to Week 48 Following Ritlecitinib Treatment: A Post Hoc Analysis
Dermatology and Therapy, Vol. 14, Núm. 10, pp. 2759-2769
-
Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO)
SKIN: Journal of Cutaneous Medicine, Vol. 8, Núm. 2, pp. S395